Slight increase in the Patents activity this week at IPO
This week’s report provides an objective analysis of Indian patent activity at the IPO, including publications, grants, and design registrations. The data reflects key trends and changes in…
1,306 articles
This week’s report provides an objective analysis of Indian patent activity at the IPO, including publications, grants, and design registrations. The data reflects key trends and changes in…
The 34th issue of the Patent Journal marks a noteworthy rise in Indian patent publications, increasing by 46.96 percent this week. This analysis covers key statistics on patent…
The Indian Patent Office’s latest data reveals a significant 32.8 percent drop in patent grants this week. The report details publication numbers, examination reports, and design registrations, providing…
This week’s review examines Indian patent and design statistics, including publication and grant trends, FER issuance, and city-wise application distribution. The analysis offers a factual summary of activity…
This week’s Indian patent statistics show a 74.58 percent increase in patent grants, with 728 applications granted. The post also covers patent publications, design registrations, and city-wise data,…
This week’s Indian patent statistics reveal a significant drop in patent grants and design registrations. The data, compiled by BananaIP Counsels, offers a detailed analysis of publication and…
Dr. Kalyan C. Kankanala explores the challenges and trends in artificial intelligence patents, with particular attention to India’s legal and patent office landscape. The article provides an objective…
Patent publications in India have doubled this week, with 879 applications published and a significant rise in design registrations. The latest statistics reflect an overall increase in intellectual…
This article summarises pivotal Delhi High Court decisions on patent disputes in 2021, particularly involving pharmaceutical products. The analysis covers interim injunctions and key arguments in Indian patent…
Bajaj Healthcare has applied for a compulsory license against Eli Lilly for Baricitinib, citing affordability concerns. The post also covers the EPO's decision on double patenting, updates from…